Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Neuroinflammation
Published in: Journal of Neuroinflammation 1/2018

Open Access 01-12-2018 | Research

β-arrestin2 functions as a key regulator in the sympathetic-triggered immunodepression after stroke

Authors: Huan Wang, Qi-Wen Deng, Ai-Ni Peng, Fang-Lan Xing, Lei Zuo, Shuo Li, Zheng-Tian Gu, Fu-Ling Yan

Published in: Journal of Neuroinflammation | Issue 1/2018

Login to get access

Abstract

Background

Stroke-induced immunodeficiency syndrome (SIDS) is regarded as a protective mechanism for secondary inflammatory injury as well as a contributor to infection complications. Although stroke-induced hyperactivation of the sympathetic system is proved to facilitate SIDS, the involved endogenous factors and pathways are largely elusive. In this study, we aim to investigate the function of beta-arrestin-2 (ARRB2) in the sympathetic-mediated SIDS.

Methods

Splenic ARRB2 expression and the sympathetic system activity were detected after establishing transient models of middle cerebral artery occlusion (MCAO). In addition, a correlation between ARRB2 expression and the sympathetic system activity was analyzed using a linear correlation analysis. Any SIDS reflected in monocyte dysfunction was investigated by measuring inflammatory cytokine secretion and neurological deficit scores and infarct volume were tested to assess neurological outcome. Further, ARRB2 expression in the monocytes was knocked down in vitro by siRNAs. Following the stimulation of noradrenaline and lipopolysaccharide, cytokine secretion and the nuclear factor-κB (NF-κB) pathway were evaluated to gain insight into the mechanisms related to the contribution of ARRB2 to adrenergic-induced monocyte dysfunction.

Results

Splenic ARRB2 expression was significantly increased after stroke and also showed a significant positive correlation with the sympathetic system activity. Stroke-induced monocyte dysfunction resulted in an increase of the interleukin-10 (IL-10) level as well as a decrease of the interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) levels. Also, blockade of adrenergic-activity significantly reversed these cytokine levels, and blockade of adrenergic-activity improved stroke-induced neurological results. However, the improved neurological results had no significant correlation with ARRB2 expression. Furthermore, the in vitro results showed that the deficiency of ARRB2 dramatically repealed adrenergic-induced monocyte dysfunction and the inhibition of NF-κB signaling phosphorylation activity.

Conclusions

ARRB2 is implicated in the sympathetic-triggered SIDS, in particular, monocyte dysfunction after stroke. Accordingly, ARRB2 may be a promising therapeutic target for the immunological management of stroke in a clinic.
Literature
1.
2.
Famakin BM. The immune response to acute focal cerebral ischemia and associated post-stroke immunodepression: a focused review. Aging Dis. 2014;5:307–26.PubMedPubMedCentral
3.
Macrez R, Ali C, Toutirais O, Le MB, Defer G, et al. Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 2011;10:471–80.CrossRefPubMed
4.
Urra X, Cervera A, Obach V, Climent N, Planas AM, Chamorro A. Monocytes are major players in the prognosis and risk of infection after acute stroke. Stroke. 2009;40:1262–8.CrossRefPubMed
5.
Urra X, Laredo C, Zhao Y, Amaro S, Rudilosso S, et al. Neuroanatomical correlates of stroke-associated infection and stroke-induced immunodepression. Brain Behav Immun. 2017;60:142–50.CrossRefPubMed
6.
Hoffmann S, Harms H, Ulm L, Nabavi DG, Mackert BM, et al. Stroke-induced immunodepression and dysphagia independently predict stroke-associated pneumonia - The PREDICT study. J Cereb Blood Flow Metab. 2017;37:3671–82.CrossRefPubMed
7.
Urra X, Obach V, Chamorro A. Stroke induced immunodepression syndrome: from bench to bedside. Curr Mol Med. 2009;9:195–202.CrossRefPubMed
8.
9.
Walter U, Kolbaske S, Patejdl R, Steinhagen V, Abu-Mugheisib M, et al. Insular stroke is associated with acute sympathetic hyperactivation and immunodepression. Eur J Neurol. 2013;20:153–9.CrossRefPubMed
10.
Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, et al. Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci. 2007;252:29–35.CrossRefPubMed
11.
Liesz A, Ruger H, Purrucker J, Zorn M, Dalpke A, et al. Stress mediators and immune dysfunction in patients with acute cerebrovascular diseases. PLoS ONE. 2013;8:e74839.CrossRefPubMedPubMedCentral
12.
13.
Romer C, Engel O, Winek K, Hochmeister S, Zhang T, et al. Blocking stroke-induced immunodeficiency increases CNS antigen-specific autoreactivity but does not worsen functional outcome after experimental stroke. J Neurosci. 2015;35:7777–94.CrossRefPubMed
14.
Lee MH, Appleton KM, Strungs EG, Kwon JY, Morinelli TA, et al. The conformational signature of beta-arrestin2 predicts its trafficking and signalling functions. Nature. 2016;531:665–8.CrossRefPubMedPubMedCentral
15.
16.
Casarini L, Reiter E, Simoni M. Beta-arrestins regulate gonadotropin receptor-mediated cell proliferation and apoptosis by controlling different FSHR or LHCGR intracellular signaling in the hGL5 cell line. Mol Cell Endocrinol. 2016;437:11–21.CrossRefPubMed
17.
Freedman NJ, Shenoy SK. Regulation of inflammation by beta-arrestins: not just receptor tales. Cell Signal. 2018;41:41–5.CrossRefPubMed
18.
Sharma D, Malik A, Steury MD, Lucas PC, Parameswaran N. Protective role of beta-arrestin2 in colitis through modulation of T-cell activation. Inflamm Bowel Dis. 2015;21:2766–77.CrossRefPubMedPubMedCentral
19.
Prass K, Meisel C, Höflich C, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med. 2003;198(5):725–36.CrossRefPubMedPubMedCentral
20.
Tureyen K, Bowen K, Liang J, Dempsey RJ, Vemuganti R. Exacerbated brain damage, edema and inflammation in type-2 diabetic mice subjected to focal ischemia. J Neurochem. 2011;116:499–507.CrossRefPubMedPubMedCentral
21.
Liu F, Schafer DP, McCullough LD. TTC, fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion. J Neurosci Methods. 2009;179:1–8.CrossRefPubMedPubMedCentral
22.
Puchowicz MA, Zechel JL, Valerio J, Emancipator DS, Xu K, et al. Neuroprotection in diet-induced ketotic rat brain after focal ischemia. J Cereb Blood Flow Metab. 2008;28:1907–16.CrossRefPubMedPubMedCentral
23.
Doll DN, Hu H, Sun J, Lewis SE, Simpkins JW, Ren X. Mitochondrial crisis in cerebrovascular endothelial cells opens the blood-brain barrier. Stroke. 2015;46(6):1681–9.CrossRefPubMedPubMedCentral
24.
Rosas-Ballina M, Olofsson PS, Ochani M, Valdés-Ferrer SI, Levine YA, Reardon C, et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science. 2011;334(6052):98–101.CrossRefPubMedPubMedCentral
25.
Chamorro A, Meisel A, Planas AM, Urra X, van de Beek D, Veltkamp R. The immunology of acute stroke. Nat Rev Neurol. 2012;8:401–10.CrossRefPubMed
26.
Liu Q, Jin WN, Liu Y, Shi K, Sun H, Zhang F, et al. Brain Ischemia suppresses immunity in the periphery and brain via different neurogenic innervations. Immunity. 2017;46(3):474–87.CrossRefPubMed
27.
28.
Wang Y, Jin L, Song Y, Zhang M, Shan D, Liu Y, et al. β-arrestin 2 mediates cardiac ischemia-reperfusion injury via inhibiting GPCR-independent cell survival signalling. Cardiovasc Res. 2017;113(13):1615–26.CrossRefPubMed
29.
Watari K, Nakaya M, Nishida M, Kim KM, Kurose H. Beta-arrestin2 in infiltrated macrophages inhibits excessive inflammation after myocardial infarction. PLoS ONE. 2013;8:e68351.CrossRefPubMedPubMedCentral
30.
Fan H, Bitto A, Zingarelli B, Luttrell LM, Borg K, et al. Beta-arrestin 2 negatively regulates sepsis-induced inflammation. Immunology. 2010;130:344–51.CrossRefPubMedPubMedCentral
31.
Xia R, Hu Z, Sun Y, Chen S, Gu M, et al. Overexpression of beta-arrestin 2 in peripheral blood mononuclear cells of patients with cryptococcal meningitis. J Interferon Cytokine Res. 2010;30:155–62.CrossRefPubMed
32.
Nuber S, Zabel U, Lorenz K, et al. β-arrestin biosensors reveal a rapid, receptor-dependent activation/deactivation cycle. Nature. 2016;531(7596):661–4.CrossRefPubMedPubMedCentral
33.
McCulloch L, Smith CJ, McColl BW. Adrenergic-mediated loss of splenic marginal zone B cells contributes to infection susceptibility after stroke. Nat Commun. 2017;8:15051.CrossRefPubMedPubMedCentral
34.
35.
Liesz A, Zhou W, Na SY, Hammerling GJ, Garbi N, et al. Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. J Neurosci. 2013;33:17350–62.CrossRefPubMed
36.
An C, Shi Y, Li P, Hu X, Gan Y, et al. Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair. Prog Neurobiol. 2014;115:6–24.CrossRefPubMed
37.
Jin R, Zhu X, Liu L, Nanda A, Granger DN, Li G. Simvastatin attenuates stroke-induced splenic atrophy and lung susceptibility to spontaneous bacterial infection in mice. Stroke. 2013;44:1135–43.CrossRefPubMedPubMedCentral
Metadata
Title
β-arrestin2 functions as a key regulator in the sympathetic-triggered immunodepression after stroke
Authors
Huan Wang
Qi-Wen Deng
Ai-Ni Peng
Fang-Lan Xing
Lei Zuo
Shuo Li
Zheng-Tian Gu
Fu-Ling Yan
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2018
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/s12974-018-1142-4

Other articles of this Issue 1/2018

Journal of Neuroinflammation 1/2018 Go to the issue

Research

Chi3l3: a potential key orchestrator of eosinophil recruitment in meningitis induced by Angiostrongylus cantonensis

Research

Sinomenine exerts anticonvulsant profile and neuroprotective activity in pentylenetetrazole kindled rats: involvement of inhibition of NLRP1 inflammasome

Research

Neuropeptide regulation of adaptive immunity in the tibia fracture model of complex regional pain syndrome

Research

Cerebrospinal fluid level of Nogo receptor 1 antagonist lateral olfactory tract usher substance (LOTUS) correlates inversely with the extent of neuroinflammation

Review

TREM2 regulates innate immunity in Alzheimer’s disease

Research

Splenic responses play an important role in remote ischemic preconditioning-mediated neuroprotection against stroke